Recursion Pharmaceuticals Profile News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Elevatus Welath Management acquired a new stake in Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 24,650 shares of the company’s stock, valued at approximately $243,000. Other institutional investors also recently bought and sold shares of the […]

Wealthspire Advisors LLC bought a new position in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 11,327 shares of the company’s stock, valued at approximately $87,000. Other institutional investors and hedge funds have […]

Allspring Global Investments Holdings LLC lifted its holdings in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 453.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 8,073 shares of the company’s stock after acquiring an additional 6,615 shares during the quarter. Allspring […]

Nikko Asset Management Americas Inc. boosted its holdings in shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Free Report) by 10.4% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 501,977 shares of the company’s stock after buying an additional 47,455 shares during the […]